4.8 Article

A Case of IL-7R Deficiency Caused by a Novel Synonymous Mutation and Implications for Mutation Screening in SCID Diagnosis

Journal

FRONTIERS IN IMMUNOLOGY
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2016.00443

Keywords

IL-7R; primary immunodeficiency; SCID; splicing; synonymous substitutions

Categories

Funding

  1. Spanish Health Research Fund [FIS PI11/1591, FIS PI16/2053, PI16/0044]
  2. Intramural Research Program of the National Human Genome Research Institute
  3. FEDER funds

Ask authors/readers for more resources

Reported synonymous substitutions are generally non-pathogenic, and rare pathogenic synonymous variants may be disregarded unless there is a high index of suspicion. In a case of IL7 receptor deficiency severe combined immunodeficiency (SCID), the relevance of a non-reported synonymous variant was only suspected through the use of additional in silico computational tools, which focused on the impact of mutations on gene splicing. The pathogenic nature of the variant was confirmed using experimental validation of the effect on mRNA splicing and IL7 pathway function. This case reinforces the need to use additional experimental methods to establish the functional impact of specific mutations, in particular for cases such as SCID where prompt diagnosis can greatly impact on diagnosis, treatment, and survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Manuel Santamaria, Olaf Neth, Jo A. Douglass, Gergely Krivan, Robin Kobbe, Ewa Bernatowska, Sofia Grigoriadou, Claire Bethune, Anita Chandra, Gerd Horneff, Michael Borte, Anja Sonnenschein, Pavlina Kralickova, Silvia Sanchez Ramon, Daman Langguth, Luis Ignacio Gonzalez-Granado, Laia Alsina, Montse Querolt, Rhonda Griffin, Carrie Hames, Elsa Mondou, Jeffrey Price, Ana Sanz, Jiang Lin

Summary: IGSC 20% demonstrated efficacy and good safety and tolerability in patients with primary immunodeficiency.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Correction Immunology

A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency (Jan, 10.1007/s10875-021-01181-6, 2022)

Manuel Santamaria, Olaf Neth, Jo A. Douglass, Gergely Krivan, Robin Kobbe, Ewa Bernatowska, Sofia Grigoriadou, Claire Bethune, Anita Chandra, Gerd Horneff, Michael Borte, Anja Sonnenschein, Pavlina Kralickova, Silvia Sanchez Ramon, Daman D. Langguth, Luis Ignacio Gonzalez-Granado, Laia Alsina, Montse Querolt, Rhonda Griffin, Carrie Hames, Elsa Mondou, Jeffrey Price, Ana Sanz, Jiang Lin

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Pediatrics

IgA deficiency and autoimmune comorbidities in juvenile idiopathic arthritis

David Torres-Fernandez, Inigo Perez-Heras, Beatriz Fernandez-Manso, Pilar Galan del Rio, Luis Ignacio Gonzalez-Granado, Jaime de Inocencio

Summary: Patients with juvenile idiopathic arthritis (JIA) frequently have autoimmune comorbidities. IgA deficiency (IgAD) does not appear to increase the prevalence of autoimmune disorders, except possibly in the case of coeliac disease (CD).

ANALES DE PEDIATRIA (2022)

Article Multidisciplinary Sciences

Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

Eva M. Garcia-Cuesta, Jose Miguel Rodriguez-Frade, Sofia R. Gardeta, Gianluca D'Agostino, Pablo Martinez, Blanca Soler Palacios, Graciela Cascio, Tobias Wolf, Nicolas Mateos, Rosa Ayala-Bueno, Cesar A. Santiago, Pilar Lucas, Lucia Llorente, Luis M. Allende, Luis Ignacio Gonzalez-Granado, Noa Martin-Cofreces, Pedro Roda-Navarro, Federica Sallusto, Francisco Sanchez-Madrid, Maria F. Garcia-Parajo, Laura Martinez-Munoz, Mario Mellado

Summary: This study reveals that the truncated mutant chemokine receptor CXCR4(R334X) associated with WHIM syndrome fails to nanoclusterize after CXCL12 stimulation, affecting cell spatial organization and mobility, and causing multiple phalloidin-positive protrusions in cells. The inappropriate activation of beta-arrestin1 by CXCR4(R334X) leads to inadequate actin cytoskeleton remodeling, disrupting the balance between activated and deactivated cofilin.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Immunology

Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients

Christoph B. Geier, Maryssa Ellison, Rachel Cruz, Sumit Pawar, Alexander Leiss-Piller, Katarina Zmajkovicova, Shannon M. McNulty, Melis Yilmaz, Martin Oman Evans, Sumai Gordon, Boglarka Ujhazi, Ivana Wiest, Hassan Abolhassani, Asghar Aghamohammadi, Sara Barmettler, Saleh Bhar, Anastasia Bondarenko, Audrey Anna Bolyard, David Buchbinder, Michaela Cada, Mirta Cavieres, James A. Connelly, David C. Dale, Ekaterina Deordieva, Morna J. Dorsey, Simon B. Drysdale, Stephan Ehl, Reem Elfeky, Francesca Fioredda, Frank Firkin, Elizabeth Forster-Waldl, Bob Geng, Vera Goda, Luis Gonzalez-Granado, Eyal Grunebaum, Elzbieta Grzesk, Sarah E. Henrickson, Anna Hilfanova, Mitsuteru Hiwatari, Chihaya Imai, Winnie Ip, Soma Jyonouchi, Hirokazu Kanegane, Yuta Kawahara, Amer M. Khojah, Vy Hong-Diep Kim, Marina Kojic, Sylwia Koltan, Gergely Krivan, Daman Langguth, Yu-Lung Lau, Daniel Leung, Maurizio Miano, Irina Mersyanova, Talal Mousallem, Mica Muskat, Flavio A. Naoum, Suzie A. Noronha, Monia Ouederni, Shuichi Ozono, G. Wendell Richmond, Inga Sakovich, Ulrich Salzer, Catharina Schuetz, Filiz Odabasi Seeborg, Svetlana O. Sharapova, Katja Sockel, Alla Volokha, Malte von Bonin, Klaus Warnatz, Oliver Wegehaupt, Geoffrey A. Weinberg, Ke-Juin Wong, Austen Worth, Huang Yu, Yulia Zharankova, Xiaodong Zhao, Lisa Devlin, Adriana Badarau, Krisztian Csomos, Marton Keszei, Joao Pereira, Arthur G. Taveras, Sarah L. Beaussant-Cohen, Mei-Sing Ong, Anna Shcherbina, Jolan E. Walter

Summary: The study describes a cohort of 66 WHIM syndrome patients, including 57 previously unreported cases, with diverse clinical phenotypes. Mutations in the same region of the CXCR4 gene lead to hyperactive signaling. The age of diagnosis and onset of clinical manifestations of WHIM syndrome vary, with earlier detection and treatment leading to better outcomes, especially in patients with a family history of the syndrome.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Allergy

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

Jennifer W. Leiding, Tiphanie P. Vogel, Valentine G. J. Santarlas, Rahul Mhaskar, Madison R. Smith, Alexandre Carisey, Alexander Vargas-Hernandez, Manuel Silva-Carmona, Maximilian Heeg, Anne Rensing-Ehl, Benedicte Neven, Jerome Hadjadj, Sophie Hambleton, Timothy Ronan Leahy, Kornvalee Meesilpavikai, Charlotte Cunningham-Rundles, Cullen M. Dutmer, Svetlana O. Sharapova, Mervi Taskinen, Ignatius Chua, Rosie Hague, Christian Klemann, Larysa Kostyuchenko, Tomohiro Morio, Akaluck Thatayatikom, Ahmet Ozen, Anna Scherbina, Cindy S. Bauer, Sarah E. Flanagan, Eleonora Gambineri, Lisa Giovannini-Chami, Jennifer Heimall, Kathleen E. Sullivan, Eric Allenspach, Nei Romberg, Sean G. Deane, Benjamin T. Prince, Melissa J. Rose, John Bohnsack, Talal Mousallem, Rohith Jesudas, Maria Marluce Dos Santos Vilela, Michael O'Sullivan, Jana Pachlopnik Schmid, Stepanka Pruhova, Adam Klocperk, Matthew Rees, Helen Su, Sami Bahna, Saf Baris, Lisa M. Bartnikas, Amy Chang Berger, Tracy A. Briggs, Shannon Brothers, Vanessa Bundy, Alice Y. Chan, Shanmuganathan Chandrakasan, Mette Christiansen, Theresa Cole, Matthew C. Cook, Mukesh M. Desai, Ute Fischer, David A. Fulcher, Silvanna Gallo, Amelie Gauthier, Andrew R. Gennery, Jose Goncalo Marques, Frederic Gottrand, Bodo Grimbacher, Eyal Grunebaum, Emma Haapaniemi, Sari Hamalainen, Kaarina Heiskanen, Tarja Heiskanen-Kosma, Hal M. Hoffman, Luis Ignacio Gonzalez-Granado, Anthony L. Guerrerio, Leena Kainulainen, Ashish Kumar, Monica G. Lawrence, Carina Levin, Timi Martelius, Olaf Neth, Peter Olbrich, Alejandro Palma, Niraj C. Patel, Tamara Pozos, Kahn Preece, Saul Oswaldo Lugo Reyes, Mark A. Russell, Yael Schejter, Christine Seroogy, Jan Sinclair, Effie Skevofilax, Daniel Suan, Daniel Suez, Paul Szabolcs, Helena Velasco, Klaus Warnatz, Kelly Walkovich, Austen Worth, Mikko R. J. Seppanen, Troy R. Torgerson, Georgios Sogkas, Stephan Ehl, Stuart G. Tangye, Megan A. Cooper, Joshua D. Milner, Lisa R. Forbes Satter

Summary: This pivotal cohort study defines the scope, natural history, treatment, and overall survival of a large global cohort of patients with pathogenic STAT3 GOF variants. The study found that patients with this variant present with a wide array of immune-mediated disease including lymphoproliferation, autoimmune cytopenias, and multisystem autoimmunity. Early identification and prompt treatment implementation are crucial for the survival of these patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Immunology

Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation

Shahrzad Bakhtiar, Celia Kaffenberger, Emilia Salzmann-Manrique, Sabine Donhauser, Leon Lueck, Neslihan Edeer Karaca, Luis Gonzalez-Granado, Esra Hazar, Sevgi Keles, Markus G. Seidel, Julia Fekadu, Christoph Koenigs, Ralf Schubert, Peter Bader, Sabine Huenecke

Summary: This study investigated the Breg profile and CD21low expressing B cells in patients with inborn errors of immunity (IEI) and overlapping clinical symptoms. The results showed significant alterations in B cell/Breg subpopulations in LRBA deficient patients and a tendency towards higher CD21low B cells in non-LRBA deficient patients. Abatacept treatment was effective in decreasing CD21low B cells in LRBA deficient patients. The findings suggest that aberrant maturation of Breg subsets and expansion of CD21low B cells may have therapeutic implications in IEI patients.

JOURNAL OF AUTOIMMUNITY (2022)

Article Immunology

Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey

Muskan Israni, Bethany Nicholson, Nizar Mahlaoui, Laura Obici, Linda Rossi-Semerano, Helen Lachmann, Georgia Hayward, Mojca Zajc Avramovic, Aurelien Guffroy, Virgil Dalm, Rachel Rimmer, Leire Solis, Carlotta Villar, Andrew R. Gennery, Stephanie Skeffington, Julia Nordin, Klaus Warnatz, Anne-Sophie Korganow, Jordi Anton, Marco Cattalini, Tania Amin, Stephan Berg, Pere Soler-Palacin, Siobhan O. Burns, Mari Campbell

Summary: This study aims to understand the prevalence and practice of transition services for young people with IEI in Europe. The survey results showed that almost all services transitioned patients to adult services, but there is a lack of standardized guidelines.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Allergy

Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations

Maria Elena Maccari, Pascal Schneider, Cristian Roberto Smulski, Andrea Meinhardt, Fernando Pinto, Luis Ignacio Gonzalez-Granado, Catharina Schuetz, Mauricio Pablo Sica, Miriam Gross, Ilka Fuchs, Patrick Kury, Maximilian Heeg, Tatjana Vocat, Laure Willen, Caroline Thomas, Regina Huehn, Aude Magerus, Myriam Lorenz, Klaus Schwarz, Frederic Rieux-Laucat, Stephan Ehl, Anne Rensing-Ehl

Summary: Heterozygous loss-of-function mutations in FASLG are better tolerated than in FAS, and usually do not result in expanded double-negative T cells (DNT) and elevated serum vitamin B12 levels, which are characteristic of autoimmune-lymphoproliferative syndrome (ALPS).

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Letter Immunology

Clinical Non-penetrance Associated with Biallelic Mutations in the RNase H2 Complex

Yanick J. Crow

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Allergy

TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

Brigette Boast, Shubham Goel, Luis I. Gonzalez-Granado, Julie Niemela, Jennifer Stoddard, Emily S. J. Edwards, Sandali Seneviratne, Dominik Spensberger, Juan F. Quesada -Espinosa, Luis M. Allende, John Mcdonnell, Alexandria Haseley, Harry Lesmana, Magdalena A. Walkiewicz, Emad Muhammad, Julian J. Bosco, Thomas A. Fleisher, Shai Cohen, Steven M. Holland, Menno C. van Zelm, Anselm Enders, Hye Sun Kuehn, Sergio D. Rosenzweig

Summary: TCF3 gene plays an important role in early lymphocyte differentiation. Mutations in TCF3 can cause immunodeficiency, but the type of genetic mutation can affect the severity and manifestation of the disease. Research suggests that monoallelic mutations in TCF3 may lead to reduced expression of TCF3 protein, B-cell defects, and dysregulated immune response.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Immunology

Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children

Marta Lopez-Nevado, Julian Sevilla, Patricia Almendro-Vazquez, Francisco J. Gil-Etayo, Sara Garcinuno, Antonio Serrano-Hernandez, Estela Paz-Artal, Luis I. Gonzalez-Granado, Luis M. Allende

Summary: Human inborn errors of immunity affecting the IFN-I induction pathway have been associated with severe viral infections, including hemophagocytic lymphohistiocytosis. This article reports a case of complete STAT2 deficiency in a child who developed HLH after vaccination and later MIS-C after SARS-CoV-2 infection. Functional studies revealed impaired IFN-I-induced response and defective IFN alpha expression, suggesting a complex mechanism for hyperinflammatory reactions in these patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

Editorial Material Pediatrics

Editorial: Primary immune regulatory disorders: Coming of age

Andrew R. Gennery, Luis I. Gonzalez-Granado, Troy R. Torgerson

FRONTIERS IN PEDIATRICS (2023)

Article Multidisciplinary Sciences

Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes

Bergithe E. Oftedal, Kristian Assing, Safa Baris, Stephanie L. Safgren, Isik S. Johansen, Marianne Antonius Jakobsen, Dusica Babovic-Vuksanovic, Katherine Agre, Eric W. Klee, Emina Majcic, Elise M. N. Ferre, Monica M. Schmitt, Tom DiMaggio, Lindsey B. Rosen, Muhammad Obaidur Rahman, Dionisio Chrysis, Aristeidi Giannakopoulos, Maria Tallon Garcia, Luis Ignacio Gonzalez-Granado, Katherine Stanley, Jessica Galant-Swafford, Pim Suwannarat, Isabelle Meyts, Michail S. Lionakis, Eystein S. Husebye

Summary: APS-1 is an autosomal recessive disease caused by mutations in the AIRE gene, characterized by severe and childhood onset organ-specific autoimmunity. Dominant-negative mutations in PHD1, PHD2, and SAND domains have also been associated with a milder phenotype. This study identified additional families with a range of phenotypes and emphasized the need for functional studies and close follow-up of individuals and families.

ISCIENCE (2023)

No Data Available